Efficacy of Ombitasvir/Paritaprevir/Ritonavir plus Ribavirin in Treatment of Chronic Hepatitis C Patients with End Stage Renal Disease on Regular Hemodialysis
Background: Hepatitis C virus (HCV) infection is associated with more significant morbidity and mortality among dialysis patients than in healthy populations. The fixed-dose tablet (ombitasvir/ paritaprevir/ritonavir) in combination with ribavirin was effective and generally well tolerated in treatm...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Al-Azhar University, Faculty of Medicine (Damietta)
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/d77cf999ebbc437a90bbcf7c9a2894ed |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|